Literature DB >> 28863287

Proving of a Mathematical Model of Cell Calculation Based on Apparent Diffusion Coefficient.

Alexey Surov1, Nikita Garnov2.   

Abstract

OBJECTIVES: Recently, Atuegwu et al. proposed a mathematical model based on ADCmean and ADCmin to calculation of cellularity. Our purpose was to compare the calculated cellularity according to the formula with the estimated cell count by histopathology in different tumors.
METHODS: For this study, we re-analyzed our previous data regarding associations between ADC parameters and histopathological findings. Overall, 134 patients with different tumors were acquired for the analysis. For all tumors, the number of tumor cells was calculated according to Atuegwu et al. 2013. We performed a correlation analysis between the calculated and estimated cellularity. Thereby, Pearson's correlation coefficient was used and P < .05 was taken to indicate statistical significance in all instances.
RESULTS: The estimated and calculated cellularity correlated well together in HNSCC (r=0.701, P=.016) and lymphomas (r=0.661, P=.001), and moderately in rectal cancer (r=0.510, P=.036). There were no statistically significant correlations between the estimated and calculated cellularity in uterine cervical cancer, meningiomas, and in thyroid cancer.
CONCLUSION: The proposed formula for cellularity calculation does not apply for all tumors. It may be used for HNSCC, cerebral lymphomas and rectal cancer, but not for uterine cervical cancer, meningioma, and thyroid cancer. Furthermore, its usefulness should be proved for other tumors.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2017        PMID: 28863287      PMCID: PMC5577394          DOI: 10.1016/j.tranon.2017.08.001

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


Introduction

Magnetic resonance imaging (MRI) is used as a staging investigation in numerous malignant diseases. Some MRI techniques, for instance, diffusion weighted imaging (DWI), are influenced by histological composition of investigated tissue, and, therefore, can be used as marker of tissue architecture [1], [2], [3], [4]. DWI measures the random motion of water molecules in tissues [1], [2]. The water diffusion can be quantified by a parameter, defined as the apparent diffusion coefficient (ADC) [1], [2], [3], [4]. ADC reflects the mobility of water within tissues and documents quantitatively restriction of water diffusion by several barriers, such as cell membranes [1], [2], [3], [4]. Therefore, ADC can indirectly provide information about cell density [1]. Previously, numerous experimental and clinical studies reported data regarding associations between DWI and histopathological features in different tumors and tumor like lesions [3], [4], [5], [6], [7]. In most publications, different ADC fractions, especially minimum ADC (ADCmin) and mean ADC (ADCmean) showed statistically significant inverse correlations with cell count in several tumors [5], [6], [7]. Recently, Atuegwu et al. proposed a mathematical model based on ADCmean and ADCmin to calculation of cellularity [8]. The authors observed a strong and significant Pearson correlation and a strong concordance correlation between the estimated and the simulated number of tumor cells [8]. However, the proposed formula was not proven by histopathological examination, and, therefore, it is unclear, if the mathematical model provides real cell count or not. Therefore, our purpose was to compare the calculated cellularity according to the formula with the estimated cell count by histopathology in different tumors.

Materials and Methods

Estimated Cellularity

For this study, we re-analyzed our previous data regarding associations between ADC parameters and histopathological findings [9], [10], [11], [12], [13], [14]. Overall, 134 patients with different tumors were acquired for the analysis (Table 1). In all cases, the diagnosis was confirmed by histopathological examination. For every tumor entity, cellularity was estimated as an average cell count per 2–5 high power fields (×400; 0.16 mm2 per field). All images were analyzed by using a research microscope Jenalumar, with camera Diagnostic instruments 4.2 as reported previously [6], [9].
Table 1

Primary Tumors, Number of Patients, and MRI Technique

EntitynMagnetic Fieldb values
Uterine cervical cancer213 Tb0 and b1000
HNSCC3 Tb0 and b800
Cerebral lymphoma211.5 Tb0 and b1000
Meningioma491.5 Tb0 and b1000
Rectal cancer173 Tb0 and b1000
Thyroid cancer153 Tb0 and b800

HNSCC, head neck squamous cell carcinoma.

Primary Tumors, Number of Patients, and MRI Technique HNSCC, head neck squamous cell carcinoma. Furthermore, in all cases the tumors were investigated by DWI. Thereby, different equipment and b values were used (Table 1).

Cell Number Calculation

For all tumors, the number of tumor cells was calculated according to Atuegwu et al. 2013 [8]. In this study, ADC values were converted to tumor cell number N using following equation: Where ADCw is the ADC of free water (ADCw = 3 × 10−3 mm2/s); ADCmin is the minimum and ADCmean the mean ADC value within the ROI, respectively. θ is the carrying capacity which can be interpreted as the maximum number of cells that can be contained within a given volume [15]. Due to varied imaging voxel sizes for different entities, we converted the given volumes to a standard volume of 1 mm3. To calculate θ, we used the tumor cell volume of 4189 μm3 [8].

Statistical Analysis

Because the fact that the formula calculated cells in a volume and previously reported data were based on cell count on high power fields, we performed a correlation analysis between the calculated and estimated cellularity. Thereby Pearson's correlation coefficient was used and P < .05 was taken to indicate statistical significance in all instances.

Results

Table 1 shows the results of the performed correlation analysis between the calculated and estimated cellularity. In the total sample, the calculated cellularity did not correlated with the estimated cell count. The subgroup analysis showed the following. Both parameters correlated well in HNSCC and lymphomas, and moderately in rectal cancer (Table 2). There were no statistically significant correlations between the estimated and calculated cellularity in uterine cervical cancer, meningiomas, and in thyroid cancer.
Table 2

Correlations Between the Estimated and Calculated Cellularity

EntitynCorrelation Coefficients
Uterine cervical cancer21r = −0.245,
P = .285
HNSCC11r = 0.701
P = .016
Cerebral lymphoma21r = 0.661
P = .001
Meningioma49r = −0.110
P = .450
Rectal cancer17= 0.510
P = .036
Thyroid cancer15r = 0.350
P = .202
Total134r = 0.119
P = .190

HNSCC, head neck squamous cell carcinoma.

Significant correlations are highlighted in bold.

Correlations Between the Estimated and Calculated Cellularity HNSCC, head neck squamous cell carcinoma. Significant correlations are highlighted in bold.

Discussion

Our study provides data about calculated and estimated cellularity in different tumors. As seen, the estimated and calculated cellularity correlated statistically significant in HNSCC, lymphoma and rectal cancer. Therefore, the proposed formula for cellularity calculation [8] can be used in clinical practice for these entities. However, there were no significant correlations between the estimated cell count and calculated cellularity in uterine cervical cancer, meningioma, and thyroid cancer. It is unclear, why the formula reflects the real cell count in some tumors, whereas in other does not. Several causes of this phenomenon are possible. The formula is based on ADC values, namely ADCmean and ADCmin and assumes that the ADC fractions correlate with cell count [8]. Recently, two meta-analyses regarding associations between ADCmean and ADCmin and cellularity were published [16], [17]. These articles identified the following: firstly, ADCmin did not better correlate with cellularity in comparison to ADCmean [17]. Secondly, different tumors showed also different associations between ADC and cell count [16]. In detail, it has been shown that correlation between ADC and cellularity ranged in different tumors [16]. Overall, the identified correlation coefficients for the analyzed tumors were as follows: glioma (ρ = −0.66), ovarian cancer (ρ = −0.64), lung cancer, (ρ = −0.63), uterine cervical cancer (ρ = −0.57), prostatic cancer (ρ = −0.56), renal cell carcinoma (ρ = −0.53), squamous cell carcinoma of head and neck (ρ = −0.53), breast cancer (ρ = −0.48), meningioma (ρ = −0.45), and lymphoma (ρ = −0.25) [16]. Another cause of our controversial results is the fact that not only cell count can influence water diffusion and ADC. It is well known that other histological factors, such as cell size and nucleic-cytoplasma ratio play a role in restriction of water diffusion [1], [2], [3]. According Matsumoto et al., increase of cell size decreased water diffusion in vitro [18]. Furthermore, it has been shown that nucleic size also affected water diffusion in cell culture [19]. The proposed formula does not consider the fact that several tumors and tumor-like lesions have different cell and nucleic sizes. Therefore, it cannot be used for all tumors. However, our study showed that it provides results, which are concordant with the estimated cell count for HNSCC, cerebral lymphoma and rectal cancer. Clearly, further investigations with different tumors are needed to proof the usefulness of the formula in other malignancies. We hypothesize that in future, more sensitive ADC-based mathematical models adjusted for every tumor entity may better reflect cellularity than a general formula. Furthermore, these models may include other ADC parameters than ADCmean and/or ADCmin. Recently, some reports showed that histogram analysis of ADC maps provided other parameters, which better correlated with tumor cell count [19], [20]. The present study has several limitations. Firstly, it is retrospective. Secondly, the analyzed tumor groups had small number of patients. In conclusion, our results suggested that the proposed formula for cellularity calculation does not apply for all tumors. It may be used for HNSCC, cerebral lymphomas and rectal cancer, but not for uterine cervical cancer, meningioma, and thyroid cancer. Furthermore, its usefulness should be checked for other tumors.
  20 in total

1.  Uncovering of intracellular water in cultured cells.

Authors:  Jean-Philippe Galons; Silvia Lope-Piedrafita; Joseph L Divijak; Curt Corum; Robert J Gillies; Theodore P Trouard
Journal:  Magn Reson Med       Date:  2005-07       Impact factor: 4.668

2.  Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas.

Authors:  Dirk Schnapauff; Martin Zeile; Manuel Ben Niederhagen; Barbara Fleige; Per-Ulf Tunn; Bernd Hamm; Oliver Dudeck
Journal:  J Magn Reson Imaging       Date:  2009-06       Impact factor: 4.813

Review 3.  Modeling tumor growth and treatment response based on quantitative imaging data.

Authors:  Thomas E Yankeelov; Nkiruka C Atuegwu; Natasha G Deane; John C Gore
Journal:  Integr Biol (Camb)       Date:  2010-07-02       Impact factor: 2.192

4.  Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.

Authors:  Munetaka Matoba; Hisao Tonami; Tamaki Kondou; Hajime Yokota; Kotaro Higashi; Hirohisa Toga; Tutomu Sakuma
Journal:  Radiology       Date:  2007-03-30       Impact factor: 11.105

5.  Assessment of the effects of cellular tissue properties on ADC measurements by numerical simulation of water diffusion.

Authors:  Kevin D Harkins; Jean-Philippe Galons; Timothy W Secomb; Theodore P Trouard
Journal:  Magn Reson Med       Date:  2009-12       Impact factor: 4.668

6.  In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology.

Authors:  Yoshitsugu Matsumoto; Masahiro Kuroda; Ryohei Matsuya; Hirokazu Kato; Koichi Shibuya; Masataka Oita; Atsushi Kawabe; Hidenobu Matsuzaki; Junichi Asaumi; Jun Murakami; Kazunori Katashima; Masakazu Ashida; Takanori Sasaki; Tetsuro Sei; Susumu Kanazawa; Seiichi Mimura; Seiichiro Oono; Takuichi Kitayama; Seiji Tahara; Keiji Inamura
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

7.  Sensitivity of MR diffusion measurements to variations in intracellular structure: effects of nuclear size.

Authors:  Junzhong Xu; Mark D Does; John C Gore
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

8.  Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.

Authors:  Nkiruka C Atuegwu; Lori R Arlinghaus; Xia Li; A Bapsi Chakravarthy; Vandana G Abramson; Melinda E Sanders; Thomas E Yankeelov
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

9.  Correlation Between Different ADC Fractions, Cell Count, Ki-67, Total Nucleic Areas and Average Nucleic Areas in Meningothelial Meningiomas.

Authors:  Alexey Surov; Henrike Caysa; Andreas Wienke; Rolf Peter Spielmann; Eckhard Fiedler
Journal:  Anticancer Res       Date:  2015-12       Impact factor: 2.480

10.  Diffusion-weighted Magnetic Resonance Imaging: What Makes Water Run Fast or Slow?

Authors:  Francesca Fornasa
Journal:  J Clin Imaging Sci       Date:  2011-05-19
View more
  2 in total

1.  Apparent Diffusion Coefficient Is a Novel Imaging Biomarker of Myopathic Changes in Liver Cirrhosis.

Authors:  Alexey Surov; Lisa Paul; Hans Jonas Meyer; Stefan Schob; Cornelius Engelmann; Andreas Wienke
Journal:  J Clin Med       Date:  2018-10-15       Impact factor: 4.241

2.  Comparison of Two Mathematical Models of Cellularity Calculation.

Authors:  Hans Jonas Meyer; Nikita Garnov; Alexey Surov
Journal:  Transl Oncol       Date:  2018-02-03       Impact factor: 4.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.